Sedative Solutions: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Sedative Solutions
Largest movements
- Cash +€49,176
up €49,176 (+288%), from €17,047 to €66,224
mainly Net result for the year (+€38,867) and Tax, wage and social debts (+€7,654)
- Reserves +€38,900
up €38,900 (+360%), from €10,800 to €49,700
- Tax, wage and social debts +€7,654
up €7,654 (+268%), from €2,851 to €10,505
- Other debts +€1,830
new in 2025: €1,830
- Gross operating margin +€36,145
up €36,145 (+263%), from €13,747 to €49,892
- Taxes +€7,655
up €7,655 (+268%), from €2,851 to €10,506
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €18,326 | €66,982 | +€48,656 | +265% |
| Fixed assets | 21/28 | €1,158 | €759 | -€399 | -34.5% |
| Tangible fixed assets | 22/27 | €1,158 | €759 | -€399 | -34.5% |
| Furniture and vehicles | 24 | €1,158 | €759 | -€399 | -34.5% |
| Current assets | 29/58 | €17,169 | €66,224 | +€49,055 | +286% |
| Cash at bank and in hand | 54/58 | €17,047 | €66,224 | +€49,176 | +288% |
| Deferred charges and accrued income | 490/1 | €122 | €0 | -€122 | -100% |
| Total equity and liabilities | 10/49 | €18,326 | €66,982 | +€48,656 | +265% |
| Equity | 10/15 | €13,849 | €52,717 | +€38,867 | +281% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €10,800 | €49,700 | +€38,900 | +360% |
| Distributable reserves | 133 | €10,800 | €49,700 | +€38,900 | +360% |
| Profit (loss) carried forward | 14 | €49 | €17 | -€33 | -66.1% |
| Amounts payable | 17/49 | €4,477 | €14,265 | +€9,788 | +219% |
| Amounts payable within one year | 42/48 | €4,477 | €14,265 | +€9,788 | +219% |
| Trade debts | 44 | €1,626 | €1,930 | +€304 | +18.7% |
| Suppliers | 440/4 | €1,626 | €1,930 | +€304 | +18.7% |
| Taxes, remuneration and social security | 45 | €2,851 | €10,505 | +€7,654 | +268% |
| Taxes | 450/3 | €2,851 | €10,505 | +€7,654 | +268% |
| Other amounts payable | 47/48 | - | €1,830 | +€1,830 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €39 | €399 | +€360 | +914% |
| Other operating charges | 640/8 | - | €63 | +€63 | |
| Gross operating margin | 9900 | €13,747 | €49,892 | +€36,145 | +263% |
| Operating profit (loss) | 9901 | €13,708 | €49,430 | +€35,722 | +261% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €8 | €57 | +€50 | +661% |
| Recurring financial charges | 65 | €8 | €57 | +€50 | +661% |
| Profit (loss) for the period before taxes | 9903 | €13,700 | €49,373 | +€35,673 | +260% |
| Income taxes | 67/77 | €2,851 | €10,506 | +€7,655 | +268% |
| Profit (loss) for the period | 9904 | €10,849 | €38,867 | +€28,018 | +258% |
| Profit (loss) for the period to be appropriated | 9905 | €10,849 | €38,867 | +€28,018 | +258% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.